Astrana Health, Inc. reiterated earnings guidance for the year ending December 31, 2024. For the year, the company expects total revenue in the range of $1,650.0 million to $1,850.0 million, Net income attributable to Astrana Health, Inc. in the range of $61.0 million to $73.0 million and EPS ? diluted in the range of $1.28 to $1.52.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.69 USD | -1.08% | -8.47% | -1.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.59% | 1.86B | |
+16.49% | 83.4B | |
-29.52% | 72.11B | |
0.00% | 27.04B | |
-13.29% | 16.96B | |
+1.03% | 16.86B | |
+1.57% | 15.76B | |
+71.63% | 13.33B | |
+1.53% | 12.76B | |
+70.68% | 12.74B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Astrana Health, Inc. Reiterates Earnings Guidance for the Year Ending December 31, 2024